Coreg CR Once-Daily Sustains Blood Pressure Reduction Over 24 Hours, Study Finds

The controlled-release version of GlaxoSmithKline’s beta blocker carvedilol has an estimated user fee date of late October.

More from Archive

More from Pink Sheet